Evidence map›Paper›PMID 33209592›Full record

ArticleTranslational lung cancer research2020

On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer.

Pierpaolo Correale, Rocco Giannicola, Rita Emilena Saladino, Valerio Nardone, Luigi Pirtoli, Pierfrancesco Tassone, Amalia Luce, Salvatore Cappabianca, Marianna Scrima, Pierosandro Tagliaferri and 1 more

Open access · diamondAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Pierpaolo CorrealeMedical Oncology Unit, Grand Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
Rocco GiannicolaMedical Oncology Unit, Grand Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
Rita Emilena SaladinoTissue Typing Unit, Grand Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
Valerio NardoneRadiotherapy Unit, "Ospedale del Mare", ASL Napoli 1, Naples, Italy.
Luigi PirtoliSbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA.
Pierfrancesco TassoneDepartment of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
Amalia LuceDepartment of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
Salvatore CappabiancaDepartment of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
Marianna ScrimaBiogem Scarl, Institute of Genetic Research, Laboratory of Precision and Molecular Oncology, Ariano Irpino, Avellino, Italy.
Pierosandro TagliaferriMedical Oncology Unit, AUO "MaterDomini", "Magna Graecia" University, Catanzaro, Italy.
Michele CaragliaDepartment of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
Azienda ospedaliera "Bianchi-Melacrino-Morelli" · ITBiogem · ITMagna Graecia University · ITUniversity of Campania "Luigi Vanvitelli" · ITOspedale D. Cotugno · ITTemple University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33209592
PMCPMC7653153
OpenAlexW3032891991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.